Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Venous Thromboembolism 1 TP53 Y220C Mutation 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Pulmonary Embolism 1 Prostatic Neoplasms, Castration-Resistant 1 Peripheral Nervous System Diseases 1 Neoplasms 1 Liver Cirrhosis 1 Leiomyosarcoma 1 Healthy Participants 1 Healthy Adult Participants 1 Endometrial Neoplasms 1 Drug-drug Interaction,SHR3680 1 Cardiotoxicity 1 Breast Neoplasms 1 Advanced Solid Malignancies 1

Interventions

Echocardiography 6 Doxorubicin 3 Carvedilol 3 empagliflozin 2 Social Determinants of Health 2 Electrocardiography 2 Cyclophosphamide 2 pegfilgrastim 1 dapagliflozin 1 Watchful Waiting 1 Vincristine 1 Vascular Stiffness 1 Trastuzumab 1 Tablets 1 Standard of Care 1 Rosuvastatin Calcium 1 Rituximab 1 Resistance Training 1 Pulse Wave Analysis 1 Prednisolone 1 Palliative Care 1 Observation 1 Methods 1 Lenalidomide 1 Hematologic Tests 1 Fenofibrate 1 Exercise Test 1 Environmental Biomarkers 1 EGFR tyrosine kinase inhibitor 324674 1 Dexrazoxane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiotoxicity × Rosuvastatin Calcium × 1 year × Clear all

NCT07254221 2025-12-10

ROSUBREAST

Shiraz University of Medical Sciences

Phase 4 Not yet recruiting

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡